Steven S. Myers - 10 Jan 2022 Form 4 Insider Report for CALADRIUS BIOSCIENCES, INC. (LSTA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Jan 2022, 15:13:45 UTC
Prior SEC filing
10 Dec 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Steven S. Myers, By: /s/ Todd C. Girolamo, Esq., Attorney-in-Fact

Key filing fact

Steven S. Myers filed Form 4 for CALADRIUS BIOSCIENCES, INC. (LSTA) on 12 Jan 2022.

Key facts

  • This page summarizes Steven S. Myers's Form 4 filing for CALADRIUS BIOSCIENCES, INC. (LSTA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Jan 2022, 15:13.

Change

  • Previous filing in this sequence was filed on 10 Dec 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LSTA transaction

Common Stock

Award

Transaction value
$0
Shares
+65,430
Change %
+45%
Price
$0.000000
Shares after
212,269
Date
10 Jan 2022
Ownership
Direct
Footnotes
F1, F2
LSTA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
8,434
Date
10 Jan 2022
Ownership
By Steven S Myers IRA
LSTA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,954
Date
10 Jan 2022
Ownership
By Steven S Myers Revocable Trust dated 12/1/2000
LSTA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
802
Date
10 Jan 2022
Ownership
By spouse
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents 65,430 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 10, 2023.

Footnote F2

Includes 103,165 unvested restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .